Literature DB >> 15968435

Phytoestrogen genistein supplementation increases eNOS and decreases caveolin-1 expression in ovariectomized rat hearts.

Yong-Bo Tang1, Qian-Lei Wang, Bing-Yang Zhu, Hong-Lin Huang, Duan-Fang Liao.   

Abstract

This study examined whether genistein influences the production of nitric oxide (NO) and expression of endothelial nitric oxide synthase (eNOS) and the modulators of eNOS activity in ovariectomized (OVX) rat hearts. Female mature Sprague-Dawley rats were subjected to bilateral ovariectomy, OVX rats were randomly divided into four groups: 17beta-estradiol (0.1 mg/kg, s.c. daily) was used as the positive control; low dose of genistein (0.5 mg/kg, s.c. daily); high dose of genistein (5.0 mg/kg, s.c. daily) and model. Sham operations as controls, the treatment lasted 6 weeks. Blood pressure, heart rate, plasma estradiol, heart and uterine weights were measured. Nitrite production in the myocardium was determined by nitrate reductase method. Protein level of eNOS, caveolin-1 and calmodulin was determined by Western blot. The results showed that nitrite production and eNOS protein in homogenized ventricular tissue was attenuated by approximately 53% and 67% in OVX rats compared with those in sham rats, respectively. Genistein increased nitrite production in rat heart in a dose-dependent manner, genistein at the dose of 5 mg/kg.d(-1) resumed nitrite production to a level similar to that in sham operated rats. Administration of genistein also increased eNOS protein expression in OVX rats myocardium with a concomitant decrease in the expression of caveolin-1, an endogenous eNOS inhibitory protein. Another eNOS stimulatory protein, calmodulin, was unchanged in these treatments. These effects were also observed in rats treated with 17beta-estradiol. Genistein at the dose of 5.0 mg/kg.d(-1) augmented uterine weight but this side effect in reproductive system was less than that of 17beta-estradiol. These results suggest that genistein supplementation and estrogen replacement therapy directly increase eNOS functional activity and NO production in the hearts of the OVX rats, but genistein has less side effects on the reproductive system than 17beta-estradiol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15968435

Source DB:  PubMed          Journal:  Sheng Li Xue Bao        ISSN: 0371-0874


  7 in total

1.  Effect of high soy diet on the cerebrovasculature and endothelial nitric oxide synthase in the ovariectomized rat.

Authors:  Derek A Schreihofer; Christian Deutsch; Tara Lovekamp-Swan; Jennifer C Sullivan; Anne M Dorrance
Journal:  Vascul Pharmacol       Date:  2010-03-01       Impact factor: 5.773

2.  Phytoestrogens regulate mRNA and protein levels of guanine nucleotide-binding protein, beta-1 subunit (GNB1) in MCF-7 cells.

Authors:  Srivatcha Naragoni; Shireesha Sankella; Kinesha Harris; Wesley G Gray
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

3.  Genistein, a soy phytoestrogen, upregulates the expression of human endothelial nitric oxide synthase and lowers blood pressure in spontaneously hypertensive rats.

Authors:  Hongwei Si; Dongmin Liu
Journal:  J Nutr       Date:  2008-02       Impact factor: 4.798

Review 4.  The role of caveolae in endothelial cell dysfunction with a focus on nutrition and environmental toxicants.

Authors:  Zuzana Majkova; Michal Toborek; Bernhard Hennig
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

5.  Role of caveolin-1 in EGCG-mediated protection against linoleic-acid-induced endothelial cell activation.

Authors:  Yuanyuan Zheng; Eum Jin Lim; Lei Wang; Eric J Smart; Michal Toborek; Bernhard Hennig
Journal:  J Nutr Biochem       Date:  2008-07-24       Impact factor: 6.048

6.  Methanolic Extract of Ceplukan Leaf (Physalis minima L.) Attenuates Ventricular Fibrosis through Inhibition of TNF-α in Ovariectomized Rats.

Authors:  Bayu Lestari; Nur Permatasari; Mohammad Saifur Rohman
Journal:  Adv Pharmacol Sci       Date:  2016-01-31

Review 7.  Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.

Authors:  Mark F McCarty
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.